Allarity Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	19.81	14.69	19.53	0.17	2.03	19.56
Short-Term Investments	-	-	-	-	-	0.35
Cash & Short-Term Investments	19.81	14.69	19.53	0.17	2.03	19.91
Cash Growth	-21.38%	-24.81%	11666.87%	-91.82%	-89.81%	1641.47%
Other Receivables	1.08	0.87	2.19	0.82	0.79	0.84
Total Trade Receivables	1.08	0.87	2.19	0.82	0.79	0.84
Other Current Assets	13.61	2.38	0.62	0.99	2.15	0.66
Total Current Assets	34.5	17.93	22.34	1.97	4.97	21.4
Net Property, Plant & Equipment	0.42	0.33	0.31	0.02	0.03	0.09
Other Intangible Assets	-	-	-	9.87	9.55	28.14
Total Assets	34.92	18.26	22.65	11.86	14.54	49.63
Accounts Payable	4.24	4.28	4.18	8.42	6.25	0.7
Accrued Expenses	2.27	2.75	5.31	1.37	1.95	8.65
Short-Term Debt	20.08	-	-	-	2.64	-
Current Portion of Long-Term Debt	1.42	1.4	1.35	1.3	-	-
Current Portion of Leases	-	-	-	-	0.01	0.1
Other Current Liabilities	-	-	0	3.08	0.37	11.27
Total Current Liabilities	28	8.43	10.84	14.17	11.22	20.72
Long-Term Debt	-	-	-	-	1.08	0.98
Long-Term Leases	-	-	-	-	-	0.01
Other Long-Term Liabilities	-	-	-	0.45	0.35	9.14
Total Long-Term Liabilities	-	-	-	0.45	1.43	10.13
Total Liabilities	28	8.43	10.84	14.61	12.65	30.85
Common Stock	0	0	0	-	-	0
Treasury Stock	-3.45	-3.19	-	-	-	-
Additional Paid-in Capital	144.4	144.23	131.13	90.37	83.16	85.24
Accumulated Other Comprehensive Income	-1.08	-1.02	-0.35	-0.41	-0.72	-0.6
Retained Earnings	-132.95	-130.2	-118.97	-94.45	-82.55	-66.49
Total Common Shareholders' Equity	6.92	9.83	11.81	-4.49	-0.11	18.15
Minority Interest	-	-	-	1.74	4.01	1.26
Shareholders' Equity	6.92	9.83	11.81	-2.75	3.89	19.42
Total Liabilities & Equity	34.92	18.26	22.65	11.86	14.54	49.63
Total Debt	21.5	1.4	1.35	1.3	3.74	1.09
Net Cash (Debt)	-1.68	13.29	18.18	-1.13	-1.71	18.82
Net Cash Growth	-	-26.93%	-	-	-	-
Net Cash Per Share	-0.11	0.92	11.31	-335.01	-3010.59	62147.88
Book Value	6.92	9.83	11.81	-4.49	-0.11	18.15
Book Value Per Share	0.44	0.68	7.35	-1327.33	-199.41	59945.20
Tangible Book Value	6.92	9.83	11.81	-14.36	-9.66	-9.98
Tangible Book Value Per Share	0.44	0.68	7.35	-4243.43	-17050.60	-32967.90

Updated May 15, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q